Zusammenfassung
In Deutschland sind ca. 250.000 bis 280.000 Personen von M. Parkinson betroffen. Im Durchschnitt sind Patienten bei Diagnosestellung 60 Jahre alt. Mit zunehmendem Alter nimmt die Erkrankungswahrscheinlichkeit zu. Die Ursache für ein idiopathisches Parkinson-Syndrom (IPS )ist noch ungeklärt. Es spielen vermutlich eine Bandbreite unterschiedlicher Faktoren eine Rolle. Der M. Parkinson ist durch ein großes Spektrum an verschiedenen Symptomen gekennzeichnet. Sie werden in motorische-, kognitiv/psychische-, vegetative-, sensorische- und Schmerzsymptome eingeteilt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur und weiterführende Literatur
Balleine B, O’Doherty J (2010) Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 35:48–69. https://doi.org/10.1038/npp.2009.131
Braak H, Del Tredici K, Rüb U, de Vos R, Jansen Steur E, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211. https://doi.org/10.1016/s0197-4580(02)00065-9. PMID: 12498954
Brown R, Jahanshahi M (1995) Depression in Parkinson’s disease: a psychosocial viewpoint. Adv Neurol 65:61–84. PMID: 7872153
Deuschl G, Bain P, Brin M (1998) Consensus statement of the movement disorder society on tremor. Ad Hoc Scientific Committee. Mov Disord 13(Suppl 3):2–23. https://doi.org/10.1002/mds.870131303. PMID: 9827589
Deuschl G, Oertel W, Reichmann H (2016) Leitlinien für Diagnostik und Therapie in der Neurologie Idiopathisches Parkinson-Syndrom Entwicklungsstufe: S3 Kurzversion, DGN, Marburg
Fereshtehnejad S, Romenets SR, Anang JBM, Latreille V, Gagnon J, Postuma RB (2015) New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol 72(8):863–873. https://doi.org/10.1001/jamaneurol.2015.0703
GBD (2016) Parkinson’s disease collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939–953. https://doi.org/10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1. PMID: 30287051; PMCID: PMC6191528.
Hacke W, Mair J, Berg D (2019) Neurologie. Springer, Berlin, S 47–51, 96, 589–604
Hawkes CH, Del Tredici K, Braak H (2007) Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599–614. https://doi.org/10.1111/j.1365-2990.2007.00874.x. Epub 2007 Oct 24. PMID: 17961138; PMCID: PMC7194308
Hemmerle AM, Herman JP, Seroogy KB (2012) Stress, depression and Parkinson’s disease. Exp Neurol 233(1):79–86. https://doi.org/10.1016/j.expneurol.2011.09.035. Epub 2011 Oct 6. PMID: 22001159; PMCID: PMC3268878
van Hilten J, Weggeman M, van der Velde E, Kerkhof G, van Dijk J, Roos R (1993) Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 5(3):235–244. https://doi.org/10.1007/BF02257678. PMID: 8369103
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortalityNeurology 50(2):318 and 16 pages following. https://doi.org/10.1212/wnl.50.2.318. PMID: 9484345.
Joshi N, Singh S (2018) Updates on immunity and inflammation in Parkinson disease pathology. J Neurosci Res 96(3):379–390. https://doi.org/10.1002/jnr.24185
Kidron D, Melamed E (1987) Forms of dystonia in patients with Parkinson’s disease. Neurology 37(6):1009–1011. https://doi.org/10.1212/wnl.37.6.1009. PMID: 3587617
Konczak J, Corcos D, Horak F, Poizner H, Shapiro M, Tuite P, Volkmann J, Maschke M (2009) Proprioception and motor control in Parkinson’s disease. J Mot Behav 41(6):543–552. https://doi.org/10.3200/35-09-002. PMID: 19592360.
de Lau L, Giesbergen P, de Rijk M, Hofman A, Koudstaal P (2004) Breteler M (2004) Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology Okt. https://doi.org/10.1212/01.WNL.0000140706.52798.BE
Lemke M, Ceballos-Baumann A (2002) Depression bei Parkinson-Patienten: diagnostische, pharmakologische und psychotherapeutische Aspekte. Dtsch Arztebl 99(40):A-2625/B-2237/C-2100
Marttila RJ, Rinne UK (1977) disability and progression in Parkinson’s disease. Acta Neurol Scand 56:159–169. https://doi.org/10.1111/j.1600-0404.1977.tb01420.x
Mazzoni P, Hristova A, Krakauer J (2007) Why don’t we move faster? Parkinson’s disease, movement vigor, and implicit motivation. J Neurosci 27(27):7105–7116. https://doi.org/10.1523/JNEUROSCI.0264-07.2007. PMID: 17611263; PMCID: PMC6794577
Menza M, Dobkin R, Marin H, Bienfait K (2010) Sleep disturbances in Parkinson’s disease. Mov Disord 25(Suppl 1):S117–S122. https://doi.org/10.1002/mds.22788
Radakovic R, Abrahams S (2018) Multidimensional apathy: evidence from neurodegenerative disease. Curr Opin Behav Sci 22:42–49. https://doi.org/10.1016/j.cobeha.2017.12.022
Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong M, Obeso JA (2010) Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nature reviews. Neuroscience 11(11):760–772. https://doi.org/10.1038/nrn2915
Richard I, Justus A, Kurlan R (2001) Relationship between mood and motor fluctuations in Parkinson’s disease. J Neuropsychiatr Clin Neurosci 13:35–41
Shetty A, Bhatia K, Lang A (2019) Dystonia and Parkinson’s disease: what is the relationship? Neurobiol Dis 132. https://doi.org/10.1016/j.nbd.2019.05.001
Spillantini M, Schmidt M, Lee VY, Trojanowski J, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839–840. https://doi.org/10.1038/42166
Sturkenboom I, Thijssen M, Gons-van Elsacker J, Jansen I, Maasdam A, Schulten M, Vijver-Visser D, Steultjens E, Bloem B, Munneke M (2008) Guidelines for Occupational Therapy in Parkinson’s Disease Rehabilitation Nijmegen. ParkinsonNet/NPF, The Netherlands/Miami
Tarakad A, Jankovic J (2019) Essential Tremor and Parkinson’s disease: exploring the relationship. Tremor Other Hyperkinet Mov (NY). https://doi.org/10.7916/D8MD0GVR. PMID: 30643667; PMCID: PMC6329774
Visanji NP, Brooks PL, Hazrati LN, Lang AE (2013) The prion hypothesis in Parkinson’s disease: Braak to the future. Acta Neuropathol Commun 1(2). https://doi.org/10.1186/2051-5960-1-2
Yoritaka A, Shimo Y, Takanashi M, Fukae J, Hatano T, Nakahara T, Miyamato N, Urabe T, Mori H, Hattori N (2013) Motor and non-motor symptoms of 1453 patients with Parkinson’s disease: prevalence and risks. Parkinsonism Relat Disord 19(8):725–731., ISSN 1353-8020. https://doi.org/10.1016/j.parkreldis.2013.04.001
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Orellana, A. (2021). Idiopathisches Parkinson-Syndrom. In: Betätigungsorientierte Ergotherapie bei Morbus Parkinson. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62583-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-62583-5_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-62582-8
Online ISBN: 978-3-662-62583-5
eBook Packages: Medicine (German Language)